Aristopharma Ltd. has launched Eloza SB 65 mg capsule, which is a Super Bioavailable form Itraconazole BP.
SUBA Itraconazole 65 mg capsule is a systemic triazole antifungal with superior bioavailability, developed using advanced SUBA Technology. It selectively inhibits fungal lanosterol 14-α-demethylase (CYP51), blocking ergosterol synthesis and weakening the fungal cell membrane. This results in loss of membrane integrity and effective suppression of fungal growth. Its pH-independent, predictable absorption delivers higher, consistent exposure at a lower dose—ensuring reliable efficacy and better patient outcomes.
FR
DE